Adma Biologics (ADMA) Other financing activities (2011 - 2025)
Adma Biologics (ADMA) posted Other financing activities of $430000.0 for Q4 2025, up 10.54% on a QoQ basis from $389000.0 in Q3 2025, and up 106.1% year-over-year from $208638.2 in Q4 2024.
Adma Biologics (ADMA) Other financing activities (2011 - 2025) Analysis & Trends
Adma Biologics' Other financing activities history runs 8 years deep, the most recent figure standing at $430000.0 for Q4 2025.
- Quarterly Other financing activities rose 106.1% year-over-year to $430000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 million (changed N/A YoY) and the FY2025 annual result came in at $3.0 million, changed N/A from the prior year.
- Other financing activities was $430000.0 for Q4 2025 at Adma Biologics, up from $389000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $5.7 million in Q3 2024 and bottomed at -$7.1 million in Q4 2024.
- A 4-year average of $490785.7 and a median of $417281.0 in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2023 — Other financing activities jumped 11011.11% — and 2024, when it sank 88237.5%.
- Adma Biologics' Other financing activities stood at $72.0 in 2022, then soared by 11011.11% to $8000.0 in 2023, then sank by 88237.5% to -$7.1 million in 2024, then jumped by 106.1% to $430000.0 in 2025.
- Business Quant data shows ADMA's Other financing activities at $430000.0 in Q4 2025, $389000.0 in Q3 2025, and $2.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 430,000.00 |
| Dec 31, 2025 | 430,000.00 |
| Sep 30, 2025 | 389,000.00 |
| Sep 30, 2025 | 389,000.00 |
| Jun 30, 2025 | 2.06 Mn |
| Jun 30, 2025 | 2.06 Mn |
| Mar 31, 2025 | 101,000.00 |
| Mar 31, 2025 | 101,000.00 |
| Dec 31, 2024 | -7.05 Mn |
| Dec 31, 2024 | -7.05 Mn |
| Sep 30, 2024 | 5.69 Mn |
| Sep 30, 2024 | 5.69 Mn |
| Jun 30, 2024 | 331,000.00 |
| Jun 30, 2024 | 331,000.00 |
| Mar 31, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 8,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Sep 30, 2023 | 624,000.00 |
| Sep 30, 2023 | 624,000.00 |